Regulating the RARα-PPARγ-CD36 cascade can reduce lipid accumulation and lipotoxicity in hepatocytes and reduce nonalcoholic steatohepatitis in mice. Here, RARA is linked to metabolic dysfunction-associated steatohepatitis.